Stephen N. Xenakis, MD (BG, USA Ret)

Medical Director for Head Injury
Psychiatry & Neurology

Dr. Xenakis is an adult, child, and adolescent psychiatrist with many years of clinical, academic, and management experience. He retired from the U.S. Army in 1998 at the rank of brigadier general and entered an active career in starting up new medical technology and clinical practices. He has advised the Chairman of the Joint Chiefs of Staff and other senior Department of Defense officials on psychological health and the effects of blast concussion. During his career in the Army, he pioneered the introduction of telemedicine applications including the development of a device for electronic house call services. He has had an active clinical and research interest in quantitative electroencephalography (qEEG). Dr. Xenakis has numerous medical publications and is an Adjunct Professor at the Uniformed Services of Health Sciences of the military medical department. He is a graduate of Princeton University and the University of Maryland School of Medicine, and has received numerous awards throughout his career as a physician and military officer. Recently, he co-founded the non-profit, Center for Translational Medicine, to advance Care Pathways (TM) for the care of veterans with brain injury and PTSD.

Dr. Xenakis relies on his understanding of brain and psychological functioning to enhance the practice of comprehensive care at the Translational Medical Group. He uses his experience as a former army general and senior clinician to develop a detailed care plan with each patient, pulling in as much objective and subjective information as he can get to understand his patient’s complaints. He is committed to securing the trust and confidence of each patient, and working with them in full partnership. Dr. Xenakis believes that current medical practice has become much too compartmentalized and has fallen short in using available information technology in the 21st century to help those suffering with chronic diseases.

Dr. Xenakis has been developing a diagnostic technique to objectively analyze brain function and help narrow the choice of treatments to those that are more likely to be effective. This method is like the familiar electrocardiogram that is used to evaluate the heart. The method is called quantitative Electroencephalography. “Quantitative electroencephalography (qEEG) involves computer-assisted imaging and statistical analysis of the EEG for detecting abnormalities, assisting the physician in making a diagnosis, and other purposes relating to patient care” (Coburn, et. al. Value of QEEG in Clinical Psychiatry). Just like the EKG shows how the heart is functioning, the qEEG can tell what is going on in the brain. It is ideal for functional brain imaging, noninvasive, and useful for customizing treatment. The Translational Medical Group uses qEEG as one of the baseline measures for developing treatment plans and care pathways. Quantitative electroencephalography (qEEG) is the only easy-to-use, flexible, and reasonably priced tool for getting objective measures of neuropsychiatric functioning of individuals. The medical practice applies the information from qEEG and questionnaires to get baseline comprehensive information on all new patients. The qEEG and questionnaires are used to monitor the patients throughout the course of treatment.

Return